Co-Diagnostics, Inc. (CODX) › Operating IncomeCo-Diagnostics, Inc. (CODX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$1.69M2017: -$4.56M2018: -$6.12M2019: -$5.89M2020: $41.69M2021: $46.06M2022: -$26.98M2023: -$42.71M2024: -$40.08M2025: -$50.17M-$50.17M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$50.17M-25.2%2024-$40.08M+6.1%2023-$42.71M-58.3%2022-$26.98M-158.6%2021$46.06M+10.5%2020$41.69M+807.4%2019-$5.89M+3.7%2018-$6.12M-34.0%2017-$4.56M-170.4%2016-$1.69M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share